与早期与晚期采用肺癌查相关的特征
Christine S Shusted1, Jan M Eberth2, Hee-Soon Juon3
1The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Preventive medicine reports
|August 5, 2024
概括
肺癌查 (LCS) 的采用率很低,但早期采用者更有可能是黑人/非裔美国人或目前的吸烟者. 了解这些采用模式是提高高风险个体及时肺癌查的关键.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 肺癌查 (LCS) 降低了死亡率,但吸收率很低.
- 查的采用遵循了提供者和公众之间的传播模式.
- 描述早期与晚期采用LCS的特征对于改善访问至关重要.
研究的目的:
- 根据其采用时间框架来描述经历LCS的个体.
- 确定与早期采用肺癌查相关的因素.
主要方法:
- 从2015年1月到2022年12月接受LCS的患者的回顾性分析.
- 根据使用USPSTF标准从符合资格到选完成的时间,对早期和晚期采用者的比较.
- 多变量回归以确定早期LCS采用的预测因素.
主要成果:
- 大多数患者 (90.4%) 根据USPSTF 2013标准符合条件;根据2021标准,9.6%符合条件.
- 黑人/非洲裔美国人和目前的吸烟者显示,早期LCS采用率显著更高 (aOR 1.428和1.514).
- 没有家族或个人癌症史的个体,早期收养的几率较低.
结论:
- 早期采用LCS的人更有可能是黑人/非裔美国人或目前的吸烟者.
- 需要进一步的研究来了解查扩散,并确定及时采用LCS的障碍.
- 制定有针对性的计划和政策可以提高整体LCS采用率.
更多相关视频
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
10.7K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
337
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
337
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
